Navigation Links
Cardiac rehabilitation saves lives
Date:6/8/2009

Waltham, MA Coronary heart disease (CHD) is the leading cause of death worldwide and a major driver of medical and economic costs, especially among older adults. It has long been established that cardiac rehabilitation improves survival, at least in middle-aged, low- and moderate-risk white men. Now a large Brandeis University-led study published in the Journal of the American College of Cardiology reports that older cardiac patients benefit as much from cardiac rehab as their younger counterparts.

Worldwide, in 2004, 7.2 million people died from CHD, while in the United States alone, more than 13 million people suffered from CHD, and almost half a million died from heart disease in 2003. Moreover, Americans aged 65 and older account for more than 55 percent of heart attacks and 86 percent of CHD deaths.

"The good news is that patients who use cardiac rehab live longer than those who do not use it, regardless of their clinical diagnosis, gender, race, or socioeconomic background" said Dr. Jose Suaya, lead author and visiting scholar at the Heller School for Social Policy and Management at Brandeis University. The study showed that "patients with different clinical backgroundsheart attacks, coronary bypass operations, and even congestive heart failureall had lower mortality when using cardiac rehab," Dr. Suaya asserted.

The study examined mortality in 601,099 Medicare beneficiaries who were hospitalized in 1997 for heart disease or bypass surgery and followed up through 2002. The study used three different statistical techniques to compare mortality between patients who used cardiac rehab and those who didn't. Overall, within a span of five years, mortality rates were 21 percent to 34 percent lower in older adult patients who used cardiac rehab. Cardiac rehab is a covered benefit under Medicare.

"Despite the significant benefits of cardiac rehab, only 12 percent of these patients actually took advantage of it," said Professor Donald Shepard, a health economist at the Heller School for Social Policy and Management at Brandeis. The regimen typically includes aerobic exercise and lifestyle counseling to reduce cholesterol, weight, and stress. The study found that patients who engaged in more than 24 sessions were an additional 19 percent less likely to die over five years than patients who used 24 sessions or fewer.

The findings are magnified among the extreme elderly and patients with other diseases, such as diabetes, on top of their heart disease. These types of patients were even less likely than others to participate, but those who did attend obtained especially large gains from cardiac rehab.

"This study should be a wake-up call to cardiac patients, their families, and their physicians that cardiac rehab can extend life and improve the quality of life, even in older people," said Dr. William Stason, senior scientist at the Heller School.

"The evidence is clear. Cardiac rehab saves lives but it is severely underused," noted Dr. Philip Ades, Professor of Cardiology at the University of Vermont and a coauthor of the study.

"The consistency of findings among the study's methodologies increases the reliability of the findings," observed Prof. Sharon-Lise Normand of Harvard Medical School and Harvard School of Public Health, another co-author of the study.

"More coronary patients should use cardiac rehab. Perhaps one way to achieve this would be to require hospitals and physicians to report rates of referrals and use of this service as quality indicators of their performance," Dr. Suaya and coauthors concluded.


'/>"/>

Contact: Laura Gardner
gardner@brandeis.edu
781-736-4204
Brandeis University
Source:Eurekalert

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Corporate and Political PR Pro to Lead Sudden Cardiac Arrest Association
3. Family History Has Strong Effect on Cardiac Risk
4. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
5. Cardiac Science to Present at the UBS Global Life Sciences Conference
6. Cardiac Science Applauds Mass AED Training of Pittsburgh Educators
7. Guidelines help patients reduce risk of cardiac event before surgery
8. Cardiac Science Named to Deloittes Technology Fast 50 for Washington State
9. Cleveland Clinic and The Larry King Cardiac Foundation Partner to Provide Heart Surgery to Those in Need
10. Cardiac Science Releases New Cardiac Rehabilitation System
11. Cardiac Artery Trouble Boosts Family Heart Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... ... with all Americans facing life-altering and fatal diseases in opposition to the ... decisions that would eviscerate care, services, and hope for the most vulnerable among ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... European Guidelines and the New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews ... http://www.fdanews.com/mdclineval                  , How will the new EU MDR language change the ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... News Advisory/Interview ... Choice has helped score a major victory in Europe for public health and the ... , Based on rigorous scientific research and the overwhelming support of European citizens, ...
(Date:3/23/2017)... ... ... “My Journey Through Heaven”: the true-life account of a man who faced death and ... Heaven for His people. “My Journey Through Heaven” is the creation of published author ... six grandchildren living and doing for God as best they can. , Published by ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... “The Trainer”: ... creation of published author, Scotty, a fiction writer with an active imagination and an ... Scotty’s new book follows the tale of Wild Bill Hart, who sat looking at ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, ... English version of the Annual report for 2016 is now ... ... NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine. ... medicines that preserve mitochondrial integrity and function in areas of ...
(Date:3/22/2017)... 2017 Research and Markets has announced the ... Trends - Industry Forecast to 2025" report to their offering. ... The Global ... of around 10.9% over the next decade to reach approximately $38.27 ... market estimates and forecasts for all the given segments on global ...
(Date:3/22/2017)... YORK , March 22, 2017 ... industry, Chinese pharmaceutical packaging market size increased year ... 2010-2016. From 2017 to 2021, the market size ... and is expected to outnumber RMB140 billion in ... policy, the rapid development of biological agents and ...
Breaking Medicine Technology: